Dr. Gerhard Nössner, Chemical Process Development
The right chemistry is key.
It goes without saying that employee safety and environmental protection are our top priorities.
Dr. Gerhard Nössner, Chemical Process Development
We offer a wide range of research and development services for active pharmaceutical ingredients.
We have a wealth of experience in synthesis.
We are well equipped for analytics, from standard methods through to NMR spectroscopy, mass
spectrometry and trace analysis.
In addition to traditional organic reactions,
we also use modern synthesis methods.
And we know our way around “green chemistry”.
It goes without saying that employee safety and environmental protection are our top priorities.
Dr. Gerhard Nössner, Chemical Process Development
This means being open about our limitations before we begin the project and offering solutions where possible.
Dr. Axel Huwe, Chemical Process Development
Developing and optimizing
chemical processes pursuant to
current guidelines, e.g. ICH Q11, M7, etc.
Characterizing final products
and intermediate steps in
API synthesis. Identifying impurities
including fate-of-impurity (FoI) studies
Feasibility studies:
Developing innovative and
eco-friendly processes
Optimizing volume
yields and throughput times
Supporting direct API
technology transfer
from customers to our
production facilities
Developing crystallizations
to adjust particle
size distributions (PSD)
Investigating crystallization
behavior, solubility
and polymorphism
(Crystal16(R), XRPD, SEM,
microscopy)
This expertise allows us to be independent, something which makes us truly proud.
Dr. Thomas Lehmann, Analytical Development
Design of
experiments
Simulation software
for technical
processes
PROCESS ANALYTICAL
TECHNOLOGY
(ReactIR(R), PVM(R),
Lasentec(R)
Reaction calorimetry,
RADEX (5 g)
and DSC (10 mg)
Laboratory
automation
– Mettler
– Optimax
– Labmax
– Systag
– Flexilab
MODERN
ANALYSIS METHODS
– GC-MS
– LC-MS (high resolution)
– NMR
– IR
– XRPD
– REM
We always check if green solvents can be used in our development steps.
Sven Stirnweiß, Process Development
We also have constant access to original citations.
This helps us to get creative when developing syntheses.
Dr. Carsten Jagusch, Process Development
PRODUCING ACTIVE PHARMACEUTICAL INGREDIENTS
We produce highly potent active pharmaceutical ingredients – from
5 kg to 20 tons.
DEVELOPMENT OF TABLETS AND CAPSULES IN THE HIGH POTENT RANGE
We develop and manufacture products in line with international standards.
ENVIRONMENTAL PROTECTION, OCCUPATIONAL SAFETY AND HEALTH
This is how we protect our colleagues and our environment.